Dune Medical Devices
Atlanta
About Dune Medical Devices
Dune Medical Devices was founded in 2002 to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. Surgeons who fight cancer on a daily basis must always contend with the lingering question, “Did I get it all?” It forces those who tackle breast cancer to consistently balance the imperative towards aggressive treatment with the desire to conserve tissue. A critical leveler in that struggle may be MarginProbe™ from Dune Medical. The MarginProbe™ System delivers real-time cancer detection in the OR for a simple and immediate assessment of cancer on the margin of excised tissue. In a randomized study of 300 breast cancer patients in Israel, the reoperation rate was reduced by 56% vs. standard of care when the MarginProbe System was employed.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.0M
- Funding stage: M&A
- Last round: Series D (Jul 2017)
- Website: dunemedical.com
- Phone: (855) 597-3863
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/dune-medical-devices-58248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.